Advance Care Planning for Older Homeless Adults
(ACP-PSH Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Facilitated Group ACP Session for older homeless adults?
Research shows that facilitated advance care planning (ACP) interventions are effective in increasing ACP uptake and satisfaction among patients with severe illnesses, and they help family carers be more involved in decision-making and reduce their stress. This suggests that similar benefits might be seen in older homeless adults participating in facilitated group ACP sessions.12345
Is advance care planning safe for older homeless adults?
How is the treatment 'Facilitated Group ACP Session' unique for older homeless adults?
What is the purpose of this trial?
The homeless population is aging, with an increasing proportion of individuals over age 50 who experience accelerated aging, high rates of mortality, and a high risk of not having their wishes honored at the end of life. The goal of this randomized control trial (RCT) is to test the effectiveness of adapted evidence-based advance care planning (ACP) interventions for formerly chronically homeless older adults living in permanent supportive housing (PSH).
Research Team
Margot Kushel, MD
Principal Investigator
University of California, San Francisco
Rebecca Sudore, MD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for formerly chronically homeless individuals over age 50 who now live in permanent supportive housing. It aims to ensure their end-of-life wishes are respected. Participants must be capable of making decisions and providing consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Co-development
Co-development of PREPARE-PSH through in-depth interviews and focus groups with PSH residents and the Community Advisory Board
Intervention
Participants attend a one-time 90-minute ACP session, either one-on-one or in a group, to review the PREPARE program
Follow-up
Participants are monitored for ACP engagement and adverse outcomes at 3 and 6 months
Treatment Details
Interventions
- Facilitated Group ACP Session
- Facilitated one-on-one ACP visits
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute on Aging (NIA)
Collaborator